A death associated with therapy for nosocomially acquired multidrug- resistant tuberculosis

Chest

Volumn 110, Issue 1, 1996, Pages 279-281

  Weltman, André C ^a,b,e   DiFerdinando Jr , George T ^a,c   Washko, Rita ^a,b   Lipsky, William M ^d  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c STATE UNIVERSITY OF NEW YORK   (United States)

^d New York City Department of Health ^*

^e PENNSYLVANIA DEPARTMENT OF HEALTH   (United States)

Author keywords

adverse effect; drug resistance; therapy; tuberculosis

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CAPREOMYCIN; CYCLOSERINE; ETHAMBUTOL; ETHIONAMIDE; ISONIAZID; OFLOXACIN; PYRAZINAMIDE; PYRIDOXINE; RIFABUTIN; RIFAMPICIN; STREPTOMYCIN; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CASE REPORT; DEATH; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER FAILURE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; OCCUPATIONAL EXPOSURE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0030000208     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.110.1.279     Document Type: Article

References (10)

1. Beck-Sague C, Dooley SW, Hutton MD, et al. Hospital outbreak of multidrug-resistant Mycobacterium tuberculosis infections: factors in transmission to stuff und HIV-infected patients. JAMA 1992; 268:1280-86
2. Pierce JH, Sims SL, Holman GH. Transmission of tuberculosis to hospital workers by a patient with AIDS. Chest 1992; 101:581-82
3. Centers for Disease Control and Prevention. Nosocomial transmission of multidrug-resistant tuberculosis among HIV-infected persons - Florida and New York. MMWR 1991; 40:585-91
4. American Thoracic Society. Treatment of tuberculosis and tuberculosis infection in adults and children. Am J Respir Crit Care Med 1994; 149:1359-74
5. Centers for Disease Control and Prevention. Management of persons exposed to multidrug resistant tuberculosis. MMWR 1992; 41(RR-11):61-71
6. Horn DL, Hewlett D, Alfalla C, et al. Limited tolerance of ofloxacin and pyrazinamide prophylaxis against tuberculosis [letter]. N Engl J Med 1994; 330:1241
7. Brausch LM, Bass JB. The treatment of tuberculosis. Med Clin North Am 1993; 77:1277-88
8. O'Brien RJ, Lyle MA, Snider DE. Rifabutin (ansamycin LM 427): a new rifamycin-S derivative for the treatment of myeobacterial diseases. Rev Infect Dis 1987; 9:519-30
9. Centers for Disease Control and Prevention. Severe isoniazid-associated hepatitis - New York, 1991-1993. MMWR 1993; 42:545-47
10. Levy SB. Confronting multidrug resistance: a role for each of us. JAMA 1993; 269:1840-42